Gene · 100302183
Papers1,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AK5 suppresses breast cancer progression and modulates anti-PD-L1 efficacy via the miR-182-5p/PD-L1 axis. | iScience | 2026 | 41907408 | PubTator, text mining | PubMed |
| ROS-Mediated Cardiomyocyte Proliferation and Myocardial Regeneration: Mechanisms and Targeted Strategies for Ischemic Heart Disease. | J Cardiovasc Dev Dis | 2026 | 41892695 | PubTator, text mining | PubMed |
| MiR-182-5p, miR-122-5p and hsa-piR-28004 as indicators of disease and treatment in pediatric familial hypercholesterolemia. | Pediatr Res | 2026 | 41820626 | PubTator, text mining | PubMed |
| Emerging Therapeutic Strategies in Asthma: Advances in Treatment, Drug Delivery, Drug Adherence, and Disease Management. | Curr Allergy Asthma Rep | 2026 | 41790360 | PubTator, text mining | PubMed |
| The role of miR-10b-5p/brain-derived neurotrophic factor axis deregulation in poststroke epileptogenesis. | Front Neurol | 2026 | 41789165 | PubTator, text mining | PubMed |
| Osteoarthritis: molecular pathogenesis and potential therapeutic options. | Signal Transduct Target Ther | 2026 | 41781374 | PubTator, text mining | PubMed |
| Investigation of miRNAs affecting schwann cells in patients with trigeminal neuralgia. | Mol Biol Rep | 2026 | 41779213 | PubTator, text mining | PubMed |
| Beyond Blood Pressure: Salt Sensitivity as a Cardiorenal Phenotype-A Narrative Review. | Life (Basel) | 2026 | 41752885 | PubTator, text mining | PubMed |
| An Exploratory Biomarker Study of First-Trimester Circulating miRNAs Associated with Later Gestational Diabetes Mellitus. | Int J Mol Sci | 2026 | 41752058 | PubTator, text mining | PubMed |
| Non-Coding RNA-Based Therapeutic Strategies in Triple-Negative Breast Cancer: A Systematic Review. | Int J Mol Sci | 2026 | 41752017 | PubTator, text mining | PubMed |
| Small-nucleolar RNA host gene3 (SNHG3) and leukemia-associated non-coding IGF1R activator RNA 1 (LUNAR1) correlated with CRC patients' clinical features: a step-toward ncRNA-precision. | Sci Rep | 2026 | 41748599 | PubTator, text mining | PubMed |
| GSCs in the Transdifferentiation Phenomenon: Focus on CAR-T-Based Therapy. | Cells | 2026 | 41744806 | PubTator, text mining | PubMed |
| Engineered Exosomes: Advances in Therapeutic Applications for Otolaryngology-Head and Neck Diseases. | Int J Nanomedicine | 2026 | 41737047 | PubTator, text mining | PubMed |
| Targetome profile of hsa-miR-93-5p is resistant to isoform formation in prostate adenocarcinoma. | PeerJ | 2026 | 41727220 | PubTator, text mining | PubMed |
| Engineered MSC-Exosomes Delivering miRNAs for Respiratory Disease Diagnostics and Therapy: Opportunities and Challenges. | Int J Nanomedicine | 2026 | 41717313 | PubTator, text mining | PubMed |
| The dual promise of extracellular vesicles in lung diseases: towards reliable biomarkers and drug delivery vectors. | Eur Respir Rev | 2026 | 41605536 | PubTator, text mining | PubMed |
| Association between miR-182 rs76481776 Polymorphism and Antidepressant Treatment Response in Patients with Depression. | Clin Psychopharmacol Neurosci | 2026 | 41582476 | PubTator, text mining | PubMed |
| Serum and Salivary microRNA Biomarkers Reveal Oxidative Stress Dysregulation in Coronary Artery Disease. | Int Dent J | 2026 | 41576725 | PubTator, text mining | PubMed |
| Renal-targeted exosomes inhibiting miR-182-5p for treatment of renal ischemia-reperfusion injury. | Bioeng Transl Med | 2026 | 41573363 | PubTator, text mining | PubMed |
| Role of hsa-miR-122-5p in chronic thromboembolic pulmonary hypertension and chronic thromboembolic disease: Targeting PIK3CG in the PI3K/Akt signaling pathway. | Medicine (Baltimore) | 2026 | 41560055 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/100302183/papers?page=2